1. Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection
- Author
-
Ana Loza, Dat Tran, Paola Sansonetti, Ignacio Martin-Loeches, Lorenzo Socias, Bianche Shum, Raúl Ortiz de Lejarazu, Yuan Fang, Jesús Blanco, David J. Kelvin, Alyson A. Kelvin, David Banner, Stéphane G. Paquette, Sigmund Krajden, Jordi Rello, Salvatore Rubino, Paula Ramirez, Raquel Almansa, Barry B. Rubin, Jesus F. Bermejo-Martin, David Andaluz, Derek C. K. Ng, Giovanni Fadda, Giovanni Delogu, Stephen S. H. Huang, Alberto J. Leόn, and Zhen Zhao
- Subjects
RNA viruses ,Viral Diseases ,medicine.medical_treatment ,lcsh:Medicine ,pandemias ,Disease ,medicine.disease_cause ,virus de la influenza A ,Mice ,Influenza A Virus, H1N1 Subtype ,Viral classification ,interleucina-6 ,Influenza A virus ,Pathology ,lcsh:Science ,infecciones por Orthomyxoviridae ,Immune Response ,Mice, Inbred BALB C ,Multidisciplinary ,Viral Load ,Innate Immunity ,Cytokine ,Infectious Diseases ,Biomarker (medicine) ,Cytokines ,Medicine ,Female ,carga viral ,Immunotherapy ,medicine.symptom ,Viral load ,Research Article ,Immune Cells ,Immunology ,Inflammation ,Immunopathology ,Biology ,Microbiology ,Immune Activation ,Immune system ,Orthomyxoviridae Infections ,Diagnostic Medicine ,Virology ,medicine ,Animals ,Interleukin 6 ,Pandemics ,Interleukin-6 ,lcsh:R ,Immunity ,Immune Defense ,Immunologic Subspecialties ,Influenza ,Mice, Inbred C57BL ,Animal Models of Infection ,Immune System ,biology.protein ,animales ,lcsh:Q ,ratones ,Pulmonary Immunology ,Biomarkers ,General Pathology - Abstract
Pandemic H1N1 influenza A (H1N1pdm) is currently a dominant circulating influenza strain worldwide. Severe cases of H1N1pdm infection are characterized by prolonged activation of the immune response, yet the specific role of inflammatory mediators in disease is poorly understood. The inflammatory cytokine IL-6 has been implicated in both seasonal and severe pandemic H1N1 influenza A (H1N1pdm) infection. Here, we investigated the role of IL-6 in severe H1N1pdm infection. We found IL-6 to be an important feature of the host response in both humans and mice infected with H1N1pdm. Elevated levels of IL-6 were associated with severe disease in patients hospitalized with H1N1pdm infection. Notably, serum IL-6 levels associated strongly with the requirement of critical care admission and were predictive of fatal outcome. In C57BL/6J, BALB/cJ, and B6129SF2/J mice, infection with A/Mexico/4108/2009 (H1N1pdm) consistently triggered severe disease and increased IL-6 levels in both lung and serum. Furthermore, in our lethal C57BL/6J mouse model of H1N1pdm infection, global gene expression analysis indicated a pronounced IL-6 associated inflammatory response. Subsequently, we examined disease and outcome in IL-6 deficient mice infected with H1N1pdm. No significant differences in survival, weight loss, viral load, or pathology were observed between IL-6 deficient and wild-type mice following infection. Taken together, our findings suggest IL-6 may be a potential disease severity biomarker, but may not be a suitable therapeutic target in cases of severe H1N1pdm infection due to our mouse data., This work was supported by the Li Ka Shing Foundation and Immune Diagnostics & Research. Dr. Alyson A. Kelvin is the Scientific Director for Immune Diagnostics & Research and had input into experimental design and write-up of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Published
- 2012